Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound agent including moxifloxacin and pidotimod

A compound preparation, the technology of moxifloxacin, is applied in the directions of pharmaceutical formulations, medical preparations with non-active ingredients, and medical preparations containing active ingredients, etc. and other problems, to achieve the effect of mobilizing endogenous anti-infection immunity, enhancing anti-infection effect, and high purity

Inactive Publication Date: 2007-09-26
YANGTZE RIVER PHARM GRP CO LTD
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Immunological studies have shown that patients with infectious diseases generally have a low level of anti-infection immunity, and relying solely on exogenous antibacterial drugs cannot completely eliminate pathogenic bacteria, and it is easy to leave hidden dangers of inducing drug resistance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound agent including moxifloxacin and pidotimod

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0022] Embodiment sees the following table:

[0023]

[0024] The beneficial effect of the present invention is further illustrated below by the curative effect report.

[0025] Efficacy report of compound preparation of moxifloxacin and pidotimod in the treatment of community-acquired pneumonia

[0026] [Objective] To observe the clinical curative effect of compound preparation of moxifloxacin and pidotimod in the treatment of community-acquired pneumonia

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a composite agent of muxixacin and pidumode, used to treat bacterial infection. The agent comprises 100-800mg muxixacin and 200-1600mg pidumode, which are both made as composite agents, that directly kills bacterial externally via the muxixacin and improve anti-infection ability via the internal anti-infection immunity ability of pidumode, with better cooperate function and wide application on general clinical bacterial infections, controlling the generations of virus infection and other abnormal pathogene infections.

Description

technical field [0001] The invention relates to a compound preparation of moxifloxacin and pidotimod for treating bacterial infectious diseases. Background technique [0002] Infectious diseases are the most common problems in clinical work, in which about 80% of infections in adults are caused by bacteria, involving outpatients and hospitalized patients. The most important means of clinical treatment of bacterial infections is the use of various antibiotics, resulting in resistance to antibiotics, and also led to problems such as complicated infections, refractory infections, and recurrent infections in the clinical treatment of such patients. At the same time, due to the increasing cycle and cost of developing new antibiotics, it is impossible to find newer and stronger antibiotics in the short term. [0003] Moxifloxacin is a product launched by Bayer AG of Germany, which belongs to the fourth-generation quinolones; chemical name: 1-cyclopropyl-7-(S,S-2,8-diazabicyclo[4....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/4709A61K9/00A61K47/40A61K47/38A61P31/04A61K31/427
Inventor 孙田江孙海胜赵文镜罗永慧王晓梅张玉斌陈成尹必喜
Owner YANGTZE RIVER PHARM GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com